You are here:-Featured

Featured Article

Creoptix launches new way of measuring kinetics to accelerate drug discovery

Creoptix, a Switzerland-based company focused on next-generation bioanalytical instruments, has launched waveRAPID (Repeated Analyte Pulses of Increasing Duration), a novel, label-free kinetic measurement method that is said to be faster than traditional kinetics. The company developed the Creoptix WAVEsystem to enable molecular interactions to be studied in real time, aimimng to revolutionise drug discovery. By

Creoptix launches new way of measuring kinetics to accelerate drug discovery2021-02-03T09:51:51+01:00

Startupticker – Privilège Ventures relies on CEOs to find promising founders

Privilège Ventures will give some of the most experienced CEOs of portfolio companies “tickets” to invest into startups run by younger, pre-seed stage founders. The first participants of the CEO scouting program will be Lea von Bidder, Emile de Rijk and Pascal König. Originally conceived by Sequoia Capital in California, one of the leading global

Startupticker – Privilège Ventures relies on CEOs to find promising founders2021-01-27T11:33:14+01:00

Meet The Disruptors: Martin Kawalski of Snowcookie Sports On The Three Things You Need To Shake Up Your Industry

As a part of our series about business leaders who are shaking things up in their industry, I had the pleasure of interviewing Martin Kawalski. Martin Kawalski, MD, Ph.D., is CEO of Snowcookie Sports — a physician and entrepreneur who uses his understanding of physiology and passion for technology to build products that enhance health

Meet The Disruptors: Martin Kawalski of Snowcookie Sports On The Three Things You Need To Shake Up Your Industry2021-01-22T10:18:30+01:00

Deliveroo completes new funding round valuing the business at over $7 Billion

  Deliveroo has completed a funding round raising a total of over $180MM from existing investors, led by Durable Capital Partners LP and Fidelity Management & Research Company LLC The funding round values Deliveroo at over $7bn The investment will enable Deliveroo to continue investing in developing the best proposition for consumers, riders and restaurants Deliveroo

Deliveroo completes new funding round valuing the business at over $7 Billion2021-01-22T17:39:48+01:00

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform

Wädenswil/Zurich, Switzerland and Saffron Walden, UK, 12th January 2021 /  Sciad Newswire / Domainex Ltd., a leading provider of integrated drug discovery services, is pleased to announce that it has invested in the WAVEdelta instrument from Creoptix AG. This instrument utilizes Grating-Coupled Interferometry (GCI) to measure target binding on sensor chips, generating binding affinity and on/off rate kinetics in a high throughput manner.

Domainex invests in the Creoptix WAVEdelta to strengthen its fragment-based drug discovery platform2021-01-14T11:47:12+01:00